Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57,709,383
-
Total 13F shares
-
51,698,203
-
Share change
-
-102,132
-
Total reported value
-
$1,717,121,218
-
Put/Call ratio
-
152%
-
Price per share
-
$33.22
-
Number of holders
-
265
-
Value change
-
-$19,969,207
-
Number of buys
-
128
-
Number of sells
-
135
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q4 2018
As of 31 Dec 2018,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
265 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,698,203 shares.
The largest 10 holders included
BlackRock Inc., Vanguard Group Inc, FMR LLC, STATE STREET CORP, Champlain Investment Partners, LLC, DIMENSIONAL FUND ADVISORS LP, Bank of New York Mellon Corp, GLENMEDE TRUST CO NA, Fiera Capital Corp, and Invesco Ltd..
This page lists
265
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.